Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease

Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease

<p>Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disease characterized by progressive glicosphingolipid accumulation in multiple organs, due to α-galactosidase a deficiency [1]. It is considered a rare disease although newborn genetic screening showed non-negligible prevalence...

Full description

Saved in:
Bibliographic Details
Main Authors: Sergio Caravita (Author), Ilaria Tanini (Author), Lia Crotti (Author), Claudia Baratto (Author), Gianfranco Parati (Author), Francesco Fattirolli (Author), Iacopo Olivotto (Author), Franco Cecchi (Author)
Format: Book
Published: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2021-11-04.
Subjects:
Short Communication
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<p>Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disease characterized by progressive glicosphingolipid accumulation in multiple organs, due to α-galactosidase a deficiency [1]. It is considered a rare disease although newborn genetic screening showed non-negligible prevalence (∼1:3.900) [1]. Cardiac manifestations include progressive Left Ventricular (LV) Hypertrophy (LVH), which may be extreme and provoke both reduced stroke volume and dynamic LV outflow tract obstruction [2-6]. </p>
DOI:10.17352/2455-2976.000173

Similar Items